COCP vs EMN · rev $105.0K vs P/E 21, rev $9.38B
Cocrystal Pharma Inc (COCP) versus Eastman Chemical Company (EMN) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
COCP currently screens at market cap $13.3M. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Not investment advice. Open the COCP and EMN stock pages for the full models.
Not investment advice.